Supraglottic Airway for Resuscitation Trial (NCT07150923) | Clinical Trial Compass
RecruitingNot Applicable
Supraglottic Airway for Resuscitation Trial
United States36,503 participantsStarted 2026-01-01
Plain-language summary
This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
Who can participate
Age range
0 Days
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Population 1: Hospital Staff
Population 1a: Clinical providers and administrators who complete study questionnaires
Clinical provider 1a inclusion criteria:
* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
* Fluent in English
Administrator 1a inclusion criteria
* Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)
* Fluent in English
Clinical provider and administrator exclusion 1a criteria: No exclusion criteria
Population 1b: Clinical providers who participate in qualitative interviews
Clinical provider 1b inclusion criteria:
* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
* Fluent in English
Clinical provider 1b exclusion criteria: No exclusion criteria
Population 2: Patients who receive neonatal resuscitation at birth
Inclusion Criteria:
* Inborn (not transferred to the hospital after birth)
* ≥34 weeks' gestation at birth, based on best obstetrical estimate
* Received PPV during neonatal resuscitation (as per provider's clinical assessment)
Exclusion Criteria:
* Congenital diaphragmatic hernia
* Airway anomalies
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.